Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the round Funds will be used to accelerate development of the Company’s gene synthesis platform, through to...
DNA synthesis
SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)
Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 (formerly known as 2019-nCoV) outbreak, including co-funding purchases of BioXp™ 3200 System. SGI-DNA is enabling...
